Cargando...
Treatment of scleromyxedema with lenalidomide, bortezomib and dexamethasone: A case report and review of the literature
Scleromyxedema is a rare and progressive disease that currently has no standard treatment. Triplet therapy with lenalidomide, bortezomib, and dexamethasone can be an effective therapy for scleromyxedema, especially in patients with refractory or relapsed disease.
Gardado en:
| Publicado en: | Clin Case Rep |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7752349/ https://ncbi.nlm.nih.gov/pubmed/33363876 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.3302 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|